Trump's Ebola remarks revive questions about Africa's role in global health security

When US President Donald Trump spoke about Ebola during discussions at the G7 summit, his remarks appeared to be a defence of American global health assistance.

But beneath the familiar language of generosity and leadership lay a deeper geopolitical argument one that once again placed Africa at the centre of global disease containment narratives.

“A couple of presidents came over, by the way, from African nations, and they were so happy with what we did,” Trump said, adding that the US had contributed approximately $375 million toward Ebola response efforts while suggesting that other global actors had given little or nothing.

The remarks revived an uncomfortable framing that has followed Ebola diplomacy for years Africa as the grateful recipient of external intervention, rather than a co-author of global health security architecture.

“...And we’ve done a good job. We’ve moved people to certain quarantines, certain locations,” he said.

The reference to “quarantines” and “locations” has raised questions.

At the time Trump was speaking in France, African health officials were engaged in a separate Ebola strategy coordination meeting. 

The contrast is not merely administrative. It reflects a structural divide in global health governance between those who frame the response and those who execute it.

President William Ruto’s presence at the G7 summit positioned him within high-level discussions on climate financing, global trade, and health security.

“Africa is not anybody’s liability,” he said, stressing that relations with global partners must move beyond aid. “It is not going to be a relationship about aid, charity or assistance,” he said.

But the parallel Ebola coordination meeting back home raises a quieter question: in moments of continental health emergencies, where does executive visibility end and operational leadership begin?

It is within this wider context that Kenya’s Ebola preparedness infrastructure has come under renewed scrutiny, particularly discussions around a proposed quarantine and isolation facility in Nanyuki, Laikipia County.

The matter has sparked legal and political debate following a court order that halted activities linked to the project, pending full disclosure of the agreement and its terms.

At the centre of the dispute is a Sh1.7 billion arrangement linked to Kenya–US cooperation on Ebola preparedness, including infrastructure development intended for isolation and response capacity.

Critics argue that details of the agreement remain insufficiently public, despite court directions requiring disclosure within a defined timeline.

Earlier this week, Health Cabinet Secretary Aden Duale appeared to shift his position on the arrangement, stating that Kenya had complied with court orders.

However, he also acknowledged that quarantine and isolation functions were still being conducted at the same facility, arguing that these were separate from the US-linked arrangement and intended instead for Kenyan troops returning from regional peacekeeping duties in the Democratic Republic of Congo.

The explanation was rejected by the Katiba Institute, which accused the government of inconsistency.

This raises the question; who controls global health security? Who owns the data generated through disease surveillance? Who controls biological samples? Who determines research priorities?

“Surveillance data generated within Kenya should, in principle, remain under Kenyan sovereignty,” says consultant pathologist Dr Ahmed Kalebi.

“While sharing is essential, there must be clear agreements on access, analysis, publication, and use. Transparency is fundamental to public trust.”

On biological samples, he warns that governance must be explicit.

“Any transfer of samples outside the country should occur under well-defined agreements specifying ownership, permissible use, intellectual property rights, and benefit-sharing.” 

On research priorities, he added that African institutions must not be reduced to implementers of externally designed agendas.

“Preparedness programmes are most effective when national governments and local scientists play an equal role in defining the research agenda,” he said.

He also noted that while Kenya’s participation in global health security brings opportunities; including infrastructure, diagnostics, and technology transfer, it also carries sovereignty risks.

“It risks being perceived as outsourcing biological risk to an African partner rather than treating Africa as an equal global-health-security partner,” he said.

Trump’s remarks, however politically framed, reflect that underlying reality. His reference to quarantine systems underscores that Ebola response is not only about treatment and vaccines, but also about surveillance, border control, and biosecurity infrastructure.

This raises a persistent question in global health diplomacy:

When wealthy nations fund disease surveillance systems, laboratories, and outbreak infrastructure in Africa, are they strengthening African resilience or extending their own first line of defence?

And when the next outbreak emerges, will Africa be recognised as an equal architect of global health security or remain the front line where global threats are contained before they travel elsewhere?